Importantly, the proliferation/survival advantage of mutp53-expressing DCIS and 4T1 cells in low AA was abolished by inhibition of either PHGDH, LAT1 or their combination (Fig. 6a, b). This evidence concerns the gene SLC7A5 and ductal breast carcinoma in situ.